Cargando…
Biomarkers of Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinv...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055235/ https://www.ncbi.nlm.nih.gov/pubmed/24963213 http://dx.doi.org/10.1155/2014/710915 |
_version_ | 1782320625079025664 |
---|---|
author | Fengming, Yi Jianbing, Wu |
author_facet | Fengming, Yi Jianbing, Wu |
author_sort | Fengming, Yi |
collection | PubMed |
description | Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease. |
format | Online Article Text |
id | pubmed-4055235 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40552352014-06-24 Biomarkers of Inflammatory Bowel Disease Fengming, Yi Jianbing, Wu Dis Markers Review Article Inflammatory bowel disease (IBD) is a chronic disease mostly involved with intestine with unknown etiology. Diagnosis, evaluation of severity, and prognosis are still present as challenges for physicians. An ideal biomarker with the characters such as simple, easy to perform, noninvasive or microinvasive, cheap, rapid, and reproducible is helpful for patients and clinicians. Currently biomarkers applied in clinic include CRP, ESR, pANCA, ASCA, and fecal calprotectin. However, they are far from ideal. Lots of studies are focused on seeking for ideal biomarker for IBD. Herein, the paper reviewed recent researches on biomarkers of IBD to get advances of biomarkers in inflammatory bowel disease. Hindawi Publishing Corporation 2014 2014-05-19 /pmc/articles/PMC4055235/ /pubmed/24963213 http://dx.doi.org/10.1155/2014/710915 Text en Copyright © 2014 Y. Fengming and W. Jianbing. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Fengming, Yi Jianbing, Wu Biomarkers of Inflammatory Bowel Disease |
title | Biomarkers of Inflammatory Bowel Disease |
title_full | Biomarkers of Inflammatory Bowel Disease |
title_fullStr | Biomarkers of Inflammatory Bowel Disease |
title_full_unstemmed | Biomarkers of Inflammatory Bowel Disease |
title_short | Biomarkers of Inflammatory Bowel Disease |
title_sort | biomarkers of inflammatory bowel disease |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055235/ https://www.ncbi.nlm.nih.gov/pubmed/24963213 http://dx.doi.org/10.1155/2014/710915 |
work_keys_str_mv | AT fengmingyi biomarkersofinflammatoryboweldisease AT jianbingwu biomarkersofinflammatoryboweldisease |